Former Executive Vice President Research & Development · BIOGEN INC. (BIIB)

Michael Ehlers

A named executive officer of BIOGEN in every fiscal year CompBrief holds from FY2016 to FY2019. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2019

$5,287,984

Salary $708,338Stock awards $4,401,172

FY2018: $7,046,651

5th of 6 named executive officers at Biogen by FY2019 total.

6 named officers on file for BIOGEN, FY2019

Michael Ehlers’s pay file — $29

  • 4 fiscal years of pay, line by line
  • 5 equity grants, each cited to its filing
  • BIIB’s disclosed peer group of 15 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how BIOGEN’s whole pay program stands against its peers

  • BIOGEN’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on BIIB→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 20, 2020 (DEF 14A).

Free

Get Michael Ehlers’s full pay file as a PDF — free

More than this page: up to 10 years of Michael’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Michael Ehlers compensation by year

BIOGEN Summary Compensation Table · all 4 fiscal years held
In US dollars, as BIOGEN reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2016FY2017FY2018FY2019
Salary$491,827$792,139$829,511$708,338
Bonus$1,170,177$0$0$0
Stock awards$3,410,650$3,157,338$5,107,535$4,401,172
Option awards$0$0$0$0
Non-equity incentive$425,062$1,012,034$917,837$0
Pension and deferred compensation$155$1,799$5,258$5,872
All other$14,665$101,671$186,510$172,602
Total$5,512,536$5,064,981$7,046,651$5,287,984

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: BIOGEN INC. DEF 14A filed April 20, 2020, accession 0001193125-20-112182, and prior-year filings. Open the filing on EDGAR.

How this page was built: the BIOGEN INC. filed document, accession 0001193125-20-112182. Every figure is read from that document and cited to the page and table it appears in. Filed April 20, 2020.

$5.5M
$5.1M
$7.0M
$5.3M
FY16
FY17
FY18
FY19
SalaryBonusNon-equity incentiveStock awardsAll other

Equity holdings

unvested awards at FY2018 year-end
TypeUnvested unitsValue at year-endExercise price
PSU11,840$3,562,893—
PSU5,442$1,637,607—
PSU5,143$1,547,632—
RSU4,735$1,424,856—
RSU4,504$1,355,344—
PSU2,502$752,902—
RSU1,821$547,975—
RSU1,501$451,681—
RSU1,036$311,753—

Per the Outstanding Equity Awards at Fiscal Year-End table in BIOGEN INC.'s FY2018 proxy; value at the fiscal year-end close, as the company printed it.

BIOGEN’s named executive officers, FY2019

as the company reported each
Named executive officerRoleFY2019 total
Michel VounatsosChief Executive Officer$18,159,858
Jeffrey CapelloExecutive Vice President and Chief Financial Officer$5,814,089
Susan AlexanderExecutive Vice President, Chief Legal Officer and Secretary$5,455,010
Alfred SandrockExecutive Vice President, Research & Development$5,312,565
Michael Ehlers · this pageFormer Executive Vice President Research & Development$5,287,984
Chirfi GuindoExecutive Vice President, Global Product Strategy And Commercialization$4,694,522

The full BIOGEN compensation record

free company brief

This page is one person within BIOGEN's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the BIOGEN proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are BIOGEN's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Michael Ehlers's compensation dossier · One-time report. No refunds.